Literature DB >> 15864345

A tax on luxury: HTLV-I infection of CD4+CD25+ Tregs.

Robert S Fujinami1.   

Abstract

Almost a quarter of a century ago, Oldstone and colleagues proposed that infection of cells by noncytopathic viruses may lead to an alteration of the cells' ability to produce certain products or perform certain tasks, i.e., inhibition of "luxury function." In this issue of the JCI, this topic has been revisited by Yamano et al., who demonstrate that human T cell lymphotropic virus type I (HTLV-I) infection of CD4(+)CD25(+) Tregs in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) results in a decrease in FOXP3 mRNA and protein expression. This leads to the inability of HTLV-I-infected CD4(+)CD25(+) Tregs to inhibit the proliferation of CD4(+)CD25(-) Tregs, due to the effect of the HTLV-I tax gene. Defects in the Treg population could be responsible for the large numbers of virus-specific T cells and occurrence of lymphoproliferation and inflammatory autoimmune disease in HAM/TSP patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864345      PMCID: PMC1087186          DOI: 10.1172/JCI25130

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

Review 1.  Development and function of CD25+CD4+ regulatory T cells.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  Curr Opin Immunol       Date:  2004-04       Impact factor: 7.486

Review 2.  CD4+ Tregs and immune control.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

3.  Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells.

Authors:  C A Piccirillo; E M Shevach
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  Virus-induced alterations in homeostasis: alteration in differentiated functions of infected cells in vivo.

Authors:  M B Oldstone; Y N Sinha; P Blount; A Tishon; M Rodriguez; R von Wedel; P W Lampert
Journal:  Science       Date:  1982-12-10       Impact factor: 47.728

5.  Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease.

Authors:  Yoshihisa Yamano; Norihiro Takenouchi; Hong-Chuan Li; Utano Tomaru; Karen Yao; Christian W Grant; Dragan A Maric; Steven Jacobson
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

6.  Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.

Authors:  Masao Satoh; Hiromu Toma; Kazuyuki Sugahara; Ken-ichiro Etoh; Yoshiyuki Shiroma; Susumu Kiyuna; Masahiro Takara; Masao Matsuoka; Kazunari Yamaguchi; Kiyonobu Nakada; Koichiro Fujita; Somei Kojima; Eitaro Hori; Yuetsu Tanaka; Shimeru Kamihira; Yoshiya Sato; Toshiki Watanabe
Journal:  Oncogene       Date:  2002-04-11       Impact factor: 9.867

7.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

8.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

9.  Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study.

Authors:  J R Orland; J Engstrom; J Fridey; R A Sacher; J W Smith; C Nass; G Garratty; B Newman; D Smith; B Wang; K Loughlin; E L Murphy
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

10.  Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease.

Authors:  Yoshihisa Yamano; Cyril J Cohen; Norihiro Takenouchi; Karen Yao; Utano Tomaru; Hong-Chuan Li; Yoram Reiter; Steven Jacobson
Journal:  J Exp Med       Date:  2004-05-10       Impact factor: 14.307

View more
  1 in total

1.  CD4+ T cell subsets and Tax expression in HTLV-1 associated diseases.

Authors:  Nicolas Barros; Jorge Risco; Carlos Rodríguez; Cesar Sánchez; Elsa González; Yuetsu Tanaka; Eduardo Gotuzzo; A Clinton White; Martin Montes
Journal:  Pathog Glob Health       Date:  2013-06       Impact factor: 2.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.